Fibroblast Growth Factor Receptor (FGFR) Inhibitors for the Treatment of Cholangiocarcinoma: Key Therapeutic ...
Introduction Cholangiocarcinoma (CCA) constitutes a heterogeneous group of aggressive malignancies arising from the biliary tree epithelium. Anatomically, these tumors are classified into intrahepatic (iCCA), perihilar (pCCA), and distal (dCCA) subtypes, …